𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Establishment of a human medulloblastoma cell line

✍ Scribed by R. M. McAllister; H. Isaacs; R. Rongey; M. Peer; W. Au; S. W. Soukup; M. B. Gardner

Publisher
John Wiley and Sons
Year
1977
Tongue
French
Weight
840 KB
Volume
20
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A cell line consisting of polygonal and fusiform cells was derived from a cerebellar medulloblastoma. Cells grew to high population density in liquid medium and formed colonies in agar medium. No neural or glial elements could be demonstrated in the cultured cells by electron microscopy nor were virus particles detected. The cells formed tumors in nude mice and in antithymocytic serum (ATS)‐treated hamsters. The tumors had a microscopic appearance similar to that of the medulloblastoma from which the cell line was derived. The cell line and lines derived from the transplant tumors in two hosts had four common “marker” chromosomes as well as non‐specific cytogenetic changes.

📜 SIMILAR VOLUMES

Establishment of a human hemangiosarcoma
Establishment of a human hemangiosarcoma cell line (ISO-HAS)
✍ Mikio Masuzawa; Takao Fujimura; Yuhko Hamada; Yuhsuke Fujita; Hisamichi Hara; Sh 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB

A cell line (ISO-HAS) has been established from tumor tissue of a human hemangiosarcoma arising on the scalp by the use of conditioned medium from a murine-phenotypic angiosarcoma cell line (ISOS-1). Cells have been cultured for more than 2 years with up to 100 passages. The cells retained endotheli

Establishment and characterization of a
Establishment and characterization of a human neuroblastoma cell line
✍ Susanna Scarpa; Carlo Dominici; Paola Grammatico; Giuseppe Del Porto; Giuseppe R 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 919 KB

A continuous human cell line RN-GA was established from a stage-Ill primary neuroblastoma prior to therapy. Light and electron microscopic analysis of the biopsy showed morphological features typical of neuroectodermal origin. Relative cellular DNA content and N-myc oncogene copy number were also an

Establishment and characterization of a
Establishment and characterization of a human myeloma cell line (KMM-1)
✍ Atsushi Togawa; Nobumasa Inoue; Huminori Hyodo; Masayoshi Namba; Kanji Miyamoto 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 821 KB

## Abstract A new cell line (KMM‐1) was established from a subcutaneous plasmacytoma of a 62‐year‐old male with multiple myeloma. Immunological studies indicated that cultured cells were derived from the same clone of myeloma cells __in vivo__: smeared cells were stained with fluoresceinconjugated

Establishment of a cell line (HCC-M) fro
Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma
✍ Tetsu Watanabe; Toshio Morizane; Kanji Tsuchimoto; Yasutaka Inagaki; Yoshio Muna 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 700 KB

## Abstract A continuous human cell line was established from a hepatocellular carcinoma of an HBsAg‐positive Japanese male. The cell line, designated HCC‐M, grows as an adhering monolayer with a doubling time of 24 h in medium RPMI‐1640 supplemented with 10% FCS and grows with 30% clonal efficienc

A hypotetraploid human T lymphoid cell l
A hypotetraploid human T lymphoid cell line established by cell fusion
✍ Kazuhiro Ishii; Junji Yodoi; Masao Hanaoka; Jun-Ichi Furuyama 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

A human T lymphoid cell line was established by cell hybridization technique from peripheral blood leucocytes of a patient with Sezary syndrome. The cells beared the surface antigens of human T lymphocyte specificity as demonstrated by immune cytolysis tests, but did not form E rosettes with sheep r

Establishment of a human non-small cell
Establishment of a human non-small cell lung cancer cell line resistant to gefitinib
✍ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosine‐kinase inhibitor gefitinib (Iressa®, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug‐resistant sublines with their parental cells are useful approaches to identifying the m